See All Slides - tctmd.com

Slides

Presentation TCT 2012

CTSN Trials: Rationale and Status

Presenter: Michael Argenziano

October 23, 2012

Presentation TCT 2012

TCT-42. Long-term Safety and Efficacy of Percutaneous Coronary Intervention with Stenting and Coronary Artery Bypass Surgery for Left Main Disease: Final Five-year Follow-up...

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

Multivessel Disease and Left Main Intervention: Indications and Outcomes

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

Presenter: Jean-Fran?ois Tanguay

October 23, 2012

Presentation TCT 2012

Pro: Ticagrelor!

Presenter: David Kong

October 23, 2012

Presentation TCT 2012

Perspective 2

Presenter: Christopher Nelson

October 23, 2012

Presentation TCT 2012

Do Beta Blockade, Afterload Reduction, and Other Medical Therapies Improve Prognosis in Functional MR? Review of the Literature and Practical Recommendations

Presenter: Jason Rogers

October 23, 2012

Presentation TCT 2012

Drug-Eluting Stent Systems: Design Differences and Comparative Effectiveness and Safety

Presenter: Duane Pinto

October 23, 2012

Presentation TCT 2012

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Presenter: Michael Lim

October 23, 2012

Presentation TCT 2012

REVA - ReZolve Clinical Program Update

Presenter: Ricardo Costa

October 23, 2012

Advertisement

Slides

CTSN Trials: Rationale and Status

TCT-42. Long-term Safety and Efficacy of Percutaneous Coronary Intervention with Stenting and Coronary Artery Bypass Surgery for Left Main Disease: Final Five-year Follow-up...

Multivessel Disease and Left Main Intervention: Indications and Outcomes

Balancing Device Polymeric Load and Long-term Absorption Will Result in the Ideal DES Platform: Bioresorbable Vascular Scaffolds Are the Future!

Pro: Ticagrelor!

Perspective 2

Do Beta Blockade, Afterload Reduction, and Other Medical Therapies Improve Prognosis in Functional MR? Review of the Literature and Practical Recommendations

Drug-Eluting Stent Systems: Design Differences and Comparative Effectiveness and Safety

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

REVA - ReZolve Clinical Program Update

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content